
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The directors take responsibility for this announcement.
Result of AGM, Resignation of Auditors and Company Update
(
AGM Results
The Company held its annual general meeting ("AGM") earlier today. The AGM was a closed meeting due to the current Covid-19 restrictions, with only the required number of members for the meeting to be quorate and all resolutions being voted by proxy. The results of the resolutions were as follows:
Resolution 1 - Receiving and Considering the Accounts
78,512,880 in favour, 0 against
The resolution was therefore passed.
Resolution 2 - Re-Appointment of Director
13,000,441 in favour, 65,398,116 against
The resolution was therefore not passed, however Ingeborg Majken Korsgård resigned as a director yesterday, as announced this morning.
Resolution 3 - Reappointment of Auditors
78,512,880 in favour, 0 against
This resolution was therefore passed, however as stated below,
Resolution 4 - Directors' Authority to Allot Shares
230,441 in favour, 78,012,439 against
The resolution was therefore not passed.
Resolution 5 - Disapplication of Pre-emption Rights
500,441 in favour, 78,012,439 against
The resolution was therefore not passed.
Resolution 6 - Authority to purchase the Company's own shares
500,441 in favour, 78,012,439 against
The resolution was therefore not passed.
Resignation of Auditors
The Company has today received a letter of resignation from
Company Update
As announced earlier today,
As announced on
Enquiries:
|
|
Media and Investors: |
020 7129 1474
|
AQSE Corporate Adviser: |
020 3328 5656 |
The directors take responsibility for this announcement.
Information on
Current Directorships
SULNOX FUEL FUSIONS LTD
KATS2020 LIMITED
PHIMEDIX PLC
Former Directorships within the previous 5 years
EQUATORIAL MINE & EXP LIMITED
EASTINCO MINING AND EXPLORATION PLC
MATTHEWS FLOWER GROUP PLC
ZAIM CREDIT SYSTEMS PLC
AMASYA RESOURCES LIMITED
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the